Long-term cause-specific mortality among five-year survivors of childhood cancer

被引:65
|
作者
Cardous-Ubbink, MC
Heinen, RC
Langeveld, NE
Bakker, PJM
Voûte, PA
Caron, HN
van Leeuwen, FE
机构
[1] Univ Amsterdam, Acad Med Ctr, Emma Kinderziekenhuis, Long Term Follow Up Clin, NL-1100 DD Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1105 AZ Amsterdam, Netherlands
[3] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands
关键词
cause-specific mortality; childhood cancer; long-term survival; mortality;
D O I
10.1002/pbc.20028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The purpose of our study was to assess long-term cause-specific mortality of 5-year childhood cancer survivors. Procedure. The study population consisted of 1,378 patients who had been treated for childhood cancer in The Netherlands between 1966 and 1996 and survived at least 5 years; follow-up was complete for 99% of survivors. Cause-specific mortality was compared with general population rates to assess relative and absolute excess risks of death (standardized mortality ratio (SMR) and AER). Results. After a median follow-up of 16.1 years, 120 patients had died. The overall SMR was 17-fold (95% Cl: 14.3-20.6) increased compared to the general population. Our cohort experienced an excess of 7 deaths per 1,000 person-years. Patients who received combined modality treatment and were treated for at least one recurrence experienced the highest risk of death (SMR = 92.3; AER = 37.0 per 1,000 person-years). The SMR appeared to stabilize at an about 4 to 5-fold increased risk of death after 20 years of follow-up. Only after more than 20 years of follow-up excess mortality due to other causes than the primary cancer exceeded mortality from the primary childhood cancer (2.3 vs. 0.3/1,000 patients/year). The SMR for all causes other than primary cancer was 5.4 in 25-year survivors. The overall risks of death strongly decreased with increasing attained age, with an SMR of 1.6 (n.s.) and an AER of 0.3 per 1 000 person-years for survivors of 30 years or older. Conclusions. The first primary cancer contributes most to the absolute excess risk of death in 5-year survivors of childhood cancer, but after 25 years childhood cancer mortality is negligible. Relative risk of death due to other causes is still significantly increased after 25 years of follow-up. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:563 / 573
页数:11
相关论文
共 50 条
  • [1] Long-term Cause-Specific Mortality Among Survivors of Childhood Cancer
    Reulen, Raoul C.
    Winter, David L.
    Frobisher, Clare
    Lancashire, Emma R.
    Stiller, Charles A.
    Jenney, Meriel E.
    Skinner, Roderick
    Stevens, Michael C.
    Hawkins, Michael M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (02): : 172 - 179
  • [2] Temporal trends in cause-specific late mortality among five-year survivors of childhood cancer
    Armstrong, G. T.
    Pan, Z.
    Ness, K.
    Srivastava, D.
    Robison, L. L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Cause-Specific Mortality in Long-Term Survivors of Retinoblastoma
    Yu, Chu-Ling
    Tucker, Margaret A.
    Abramson, David H.
    Furukawa, Kyoji
    Seddon, Johanna M.
    Stovall, Marilyn
    Fraumeni, Joseph F., Jr.
    Kleinerman, Ruth A.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (08) : 581 - 591
  • [4] Population-based long-term cause-specific mortality among 34,489 5-year survivors of childhood cancer
    Fidler, Miranda
    Reulen, Raoul
    Kelly, Julie
    Frobisher, Clare
    Winter, David
    Hawkins, Michael
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2015, 24 : 45 - 45
  • [5] Cause-specific long-term mortality in survivors of childhood cancer in Switzerland: A population-based study
    Schindler, Matthias
    Spycher, Ben D.
    Ammann, Roland A.
    Ansari, Marc
    Michel, Gisela
    Kuehni, Claudia E.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (02) : 322 - 333
  • [6] Impact of era of diagnosis on cause-specific late mortality among 77 423 five-year European survivors of childhood and adolescent cancer: The PanCareSurFup consortium
    Byrne, Julianne
    Schmidtmann, Irene
    Rashid, Humayra
    Hagberg, Oskar
    Bagnasco, Francesca
    Bardi, Edit
    De Vathaire, Florent
    Essiaf, Samir
    Winther, Jeanette Falck
    Frey, Eva
    Gudmundsdottir, Thorgerdur
    Haupt, Riccardo
    Hawkins, Michael M.
    Jakab, Zsuzsanna
    Jankovic, Momcilo
    Kaatsch, Peter
    Kremer, Leontien C. M.
    Kuehni, Claudia E.
    Harila-Saari, Arja
    Levitt, Gill
    Reulen, Raoul
    Ronckers, Cecile M.
    Maule, Milena
    Skinner, Roderick
    Steliarova-Foucher, Eva
    Terenziani, Monic
    Zaletel, Lorna Zadravec
    Hjorth, Lars
    Garwicz, Stanislaw
    Grabow, Desiree
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (03) : 406 - 419
  • [7] Population-Based Long-Term Cardiac-Specific Mortality Among 34 489 Five-Year Survivors of Childhood Cancer in Great Britain
    Fidler, Miranda M.
    Reulen, Raoul C.
    Henson, Katherine
    Kelly, Julie
    Cutter, David
    Levitt, Gill A.
    Frobisher, Clare
    Winter, David L.
    Hawkins, Michael M.
    [J]. CIRCULATION, 2017, 135 (10) : 951 - +
  • [8] Long term mortality of five-year survivors of childhood cancer in Rhone-Alpes region
    Trombert-Paviot, B.
    Frappaz, D.
    Casagranda, L.
    Plantaz, D.
    Bertrand, Y.
    Stephan, J. -L.
    Berger, C.
    Freycon, F.
    [J]. REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2008, 56 (06): : 383 - 390
  • [9] Cause-specific late mortality among 5-year survivors of childhood cancer: The childhood cancer survivor study
    Mertens, Ann C.
    Liu, Qi
    Neglia, Joseph P.
    Wasilewski, Karen
    Leisenring, Wendy
    Armstrong, Gregory T.
    Robison, Leslie L.
    Yasui, Yutaka
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (19) : 1368 - 1379
  • [10] Temporal Trends in Cause-Specific Late Mortality Among 5-Year Survivors of Childhood Cancer
    Armstrong, Gregory T.
    Pan, Zhenyu
    Ness, Kirsten K.
    Srivastava, Deokumar
    Robison, Leslie L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) : 1224 - 1231